Current Progresses on Nanodelivery Systems for the Treatment of Neuropsychiatric Diseases: Alzheimer’s and Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|41|7185-7195

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.41, 2013-12, pp. : 7185-7195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flavonoids in the Treatment of Alzheimer’s and Other Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 25, Iss. 27, 2018-08 ,pp. : 3228-3246

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Current Approaches in the Treatment of Neuropsychiatric Diseases)

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3383-3384

Bentham Science Publishers

Access to resources Recommend Favorite

Current status and new developments with galantamine in the treatment of Alzheimer’s disease

By Tariot Pierre  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 2027-2049

Informa Healthcare

Access to resources Recommend Favorite

Current strategies for the treatment of Alzheimer’s disease and other tauopathies

By Dickey Chad A   Petrucelli Leonard  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 665-676

Informa Healthcare

Access to resources Recommend Favorite

Novel Drug Delivery Systems for Releasing Growth Factors to the CNS: Focus on Alzheimer’s and Parkinson’s Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 7, 2014-06 ,pp. : 557-566

Bentham Science Publishers

Access to resources Recommend Favorite